Chen Chen
The University of Queensland
Queens University
Australia
Biography
After training as MBBS at Fudan University Medical School in 1982, Professor Chen completed PhD in Neuroscience at the University of Bordeaux, France in 1989. He worked as a researcher in Glaxo Inc. in the U.S.A. and then headed Endocrine Cell Biology at the Prince Henry’s Institute of Medical Reserach (Melbourne) till 2007. He moved to his current post at the beginning of 2008. His work focused on the metabolic disorders in relation to neuroendocrinology, diabetes, cardiomyopathy and endometrial cancers. He has published more than 130 papers in top international scientific journals. He served as Chair of many international conferences and as editorial member of many international journals. After training as MBBS at Fudan University Medical School in 1982, Professor Chen completed PhD in Neuroscience at the University of Bordeaux, France in 1989. He worked as a researcher in Glaxo Inc. in the U.S.A. and then headed Endocrine Cell Biology at the Prince Henry’s Institute of Medical Reserach (Melbourne) till 2007. He moved to his current post at the beginning of 2008. His work focused on the metabolic disorders in relation to neuroendocrinology, diabetes, cardiomyopathy and endometrial cancers. He has published more than 130 papers in top international scientific journals. He served as Chair of many international conferences and as editorial member of many international journals.
Research Interest
The Endocrinology laboratory focuses on the link of cell biological properties and functions. Functions of cells may be the secretion of hormones in endocrine cells, contraction and dilation of cardiomyocytes, or proliferation and apoptosis of cancer cells. We concentrate on hormones, which are important in controlling growth, development, metabolic balance, body mass composition, ageing process, and the plasma glucose levels, such as growth hormone, leptin, orexin, insulin, glucagon, and adipocyte-derived hormones and factors. Several endogenous and synthetic regulatory peptides have been tested for their regulatory roles in pituitary and pancreatic islet
